Ahmad Alenezi: Harrison.ai Secured Its 13th FDA Clearance, And This One Is a Literal Life-Saver
Ahmad Alenezi, Nuclear Medicine Technology Specialist, Assistant Professor at Kuwait University, shared on LinkedIn:
”Big news for the stroke care community!
Harrison.ai just secured its 13th FDA clearance, and this one is a literal life-saver.
They have developed the first AI cleared to triage acute ischemic stroke (tissue injury) on a patient’s very first non-contrast CT scan.
Why this matters?:
In stroke care, ‘time is brain.’
Traditionally, AI needed a second, more complex scan (CTA) to flag a blockage.
By catching signs of injury on the initial ER scan, we’re cutting down the ‘door-to-needle’ time when every second counts toward a patient’s recovery.
This isn’t just about faster tech, it’s about getting clinicians the right data earlier to prevent permanent disability.
Huge win for the team and a massive step forward for emergency radiology.
Those milestones and developments necessitate the integration of AI medical education in our syllabus.”
Stay updated with Hemostasis Today.
-
Jul 6, 2026, 04:36Sarah Richardson: On Capitol Hill, Speaking Up for Patients
-
Jul 5, 2026, 23:26Nominations Now Open for the First Nations Stroke Excellence Award – Stroke Foundation
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation